Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and
Frankfurt: “6BX”) (the “
Company”
or “
Relevium”), is pleased to
announce the national screening of “Weed the People” across eight
Canadian cities on January 15, 2019.
Relevium Technologies, in partnership with
Executive Producer Ricki Lake, Director Abby Epstein and
Cannakids.org, will be conducting a nation-wide screening of Weed
the People, a compelling, emotional and educational film that
explores the potential benefits of medical cannabis oils for
pediatric applications. The film follows the journey of five
families dealing with children suffering from cancer and the
introduction of cannabis oil to treat their children following the
failure of conventional treatments. The families in the documentary
pursue the use of cannabis alongside conventional treatments,
including chemotherapy and radiation, revealing thought-provoking
outcomes that support further research and exposing the legal
contextual hurdles faced by these parents as they pursue lifesaving
alternatives for their children.
Relevium Technologies recently announced the
exclusive license from Cannakids’ to introduce medical cannabis
formulations, SOPs and branding into the Canadian market to pursue
pediatric applications and support ongoing research. Tracy Ryan,
the CEO of CK Properties and its brand Cannakids, and her family
are one of the five families described in the film, which also
tells the story of her motivation to enter into the medical
cannabis business to support her daughter’s battle against
cancer.
Aurelio Useche, CEO of Relevium Technologies
stated: “The film is an amazing journey into the potential
opportunities of complementing traditional treatments for Cancer
and other illness in Pediatric patients.” Mr. Useche stated
further: “We at Relevium are committed to introduce and further
develop these possibilities, which is why we feel everyone should
attend the screening of this amazing documentary, a film that not
only opens a potential door for hope for patients and their
families, but also further validates the legalization of Cannabis
in Canada by the Canadian Government and by our prime minister
Justin Trudeau.”
Relevium Technologies would like to invite our
shareholders, industry leaders, the general public as well as the
medical and scientific community to the national screenings which
will take place in eight (8) Canadian cities on January 15, 2019 as
follows:
Toronto: January 15th, 2019 @
7pm Cineplex Yonge-Dundas and VIP 10 Dundas St E
#402, Toronto, ON, M5B 2G9, Canada
Tickets: https://tickets.demand.film/event/6782
|
Vancouver: January 15th, 2019 @
7pm Cineplex Odeon International Village
Cinemas International Village Mall, Vancouver, BC, V6B 6N9,
Canada
Tickets: https://tickets.demand.film/event/6783
|
Montreal: January 15th, 2019 @
7pm Cineplex Odeon Quartier Latin Cinemas 350 Rue Émery,
Montréal, QC, H2X 1J1, Canada
Tickets: https://tickets.demand.film/event/6784
|
Ottawa: January 15th, 2019 @
7pm Cineplex Odeon South Keys Cinemas SmartREIT, Ottawa,
ON, K1V 1J6, Canada
Tickets: https://tickets.demand.film/event/6785
|
Calgary: January 15th, 2019 @
6pm Cineplex Odeon Eau Claire Market Cinemas Eau Claire
Market, Calgary, AB, T2P 4R5, Canada
Tickets: https://tickets.demand.film/event/6787
|
Edmonton: January 15th, 2019 @
7pm Cineplex Odeon South Edmonton Cinemas South
Edmonton Common, Edmonton, AB, T6N 1K5, Canada
Tickets: https://tickets.demand.film/event/6786
|
Winnipeg: January 15th, 2019 @
7pm Cineplex Odeon McGillivray Cinemas and VIP 2190
McGillivray Blvd, Winnipeg, MB, R3Y 1S6,
Canada Tickets: https://tickets.demand.film/event/6788
|
Halifax: January
15th, 2019 @ 7pm Cineplex Park Lane Park Lane Mall,
Halifax, NS, B3J 3R4,
Canada Tickets: https://tickets.demand.film/event/6789
|
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in policies
of the TSX Venture Exchange) accepts responsibility for the
adequacy or accuracy of this release.
About Abby Epstein and Ricki
LakeThe makers of the film, Abby Epstein and Ricki Lake
have produced and directed ground-breaking documentaries including
"The Business of Being Born", "Sweetening the Pill", "The Mama
Sherpas" and now "Weed the People".
Abby Epstein is a film director and
producer, and an award-winning play director. Prior to her
film work, Abby directed theatre productions of "RENT" and "The
Vagina Monologues."
Ricki Lake is an American film actress and
television host best known for her starring role in the original
movie "Hairspray" and for her daytime talk show, "The Ricki Lake
Show" which aired for 11 seasons until 2005. The show
returned in 2012 and resulted in Ricki winning an Emmy.
About Relevium
TechnologiesRelevium is a publicly-traded company that
operates in the health and wellness industry, including legal
cannabis, with a primary focus on online distribution. The
principal business of the Company is the identification,
evaluation, acquisition and operations of brands and businesses in
the Health and Wellness markets and medical cannabis. The Company
pursues its business strategy through an acquisition and
partnership model in a holistic approach to encompass a wide range
of health and wellness consumer products. Relevium operates through
two wholly-owned subsidiaries:
BGX E-Health LLC (BGX): Based
in Orlando, Florida, BGX markets dietary supplements,
nutraceuticals, sports nutrition and cosmeceuticals primarily
through its Bioganix® brand portfolio in the US and Europe.
Relevium’s brands such as Bioganix® are sold at some of
the world’s largest retailers including such as Walmart.com and
Amazon.com.
The Company’s strategy for growing its brands
includes expanding its product offering, adding new distribution
channels and developing partnerships that add value through
exclusive ingredients. BGX is currently testing a complete line of
dietary supplements derived from Cannabis with an initial focus on
hemp derived, whole plant organic extract rich in CBD
(cannabidiol). The product line will be marketed through its brand
LeefyLyfe® and will be sold first in Europe and then North America.
The Company uses cannabinoids and ingredients that have achieved
GRAS status (generally accepted as safe) to create brands that are
sold via wholesale channels, retail channels and online
distribution.
Biocannabix Health Corporation
(BCX): Based in Montreal, Quebec, BCX is an
entrepreneurial venture to establish a vertically integrated
research based medical cannabis company in the Nutraceutical
space.
Cautionary Note Regarding
Forward-Looking StatementsThis release includes certain
statements and information that may constitute forward-looking
information within the meaning of applicable Canadian securities
laws. All statements in this news release, other than statements of
historical facts, including statements regarding future estimates,
plans, objectives, assumptions or expectations of future
performance, including the timing and completion of the proposed
acquisitions, are forward-looking statements and contain
forward-looking information. Generally, forward- looking statements
and information can be identified by the use of forward-looking
terminology such as "intends" or "anticipates", or variations of
such words and phrases or statements that certain actions, events
or results "may", "could", "should", "would" or "occur".
Forward-looking statements are based on certain material
assumptions and analysis made by the Company and the opinions and
estimates of management as of the date of this press release,
including the assumptions that the Company will be able to apply
for and ultimately obtain an ACMPR licence, the proposed business
of Biocannabix will develop as anticipated, that the Company will
raise sufficient funds to develop the Biocannabix business, and
that the Company will obtain all requisite regulatory approvals.
These forward-looking statements are subject to known and unknown
risks, uncertainties and other factors that may cause the actual
results, level of activity, performance or achievements of the
Company to be materially different from those expressed or implied
by such forward-looking statements or forward-looking information.
Important factors that may cause actual results to vary, include,
without limitation, the risk that the proposed business
developments may not occur as planned; the timing and receipt of
requisite approvals and failure to raise sufficient funds.
Although management of the Company has attempted
to identify important factors that could cause actual results to
differ materially from those contained in forward-looking
statements or forward-looking information, there may be other
factors that cause results not to be as anticipated, estimated or
intended. There can be no assurance that such statements will prove
to be accurate, as actual results and future events could differ
materially from those anticipated in such statements. Accordingly,
readers should not place undue reliance on forward-looking
statements and forward-looking information. Readers are cautioned
that reliance on such information may not be appropriate for other
purposes. The Company does not undertake to update any
forward-looking statement, forward-looking information or financial
outlook that are incorporated by reference herein, except in
accordance with applicable securities laws. We seek safe
harbor.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES
INC.
Aurelio UsechePresident and CEO
For more information about this press release:
Tel: +1.888.528.8687RELEVIUM TECHNOLOGIES
INCEmail: investors@releviumcorp.com Website:
www.releviumtechnologies.com Like us on
Facebook Follow us on Twitter Follow us on
LinkedIn
Relevium Technologies (TSXV:RLV)
Historical Stock Chart
From Jun 2024 to Jul 2024
Relevium Technologies (TSXV:RLV)
Historical Stock Chart
From Jul 2023 to Jul 2024